Rite Aid Pharmacy #11011 | |
600 Chestnut Ave, Altoona, Pennsylvania 16601 | |
(814) 943-0545 |
Name | Rite Aid Pharmacy #11011 |
---|---|
Organization Name | Thrift Drug Inc |
Location | 600 Chestnut Ave, Altoona, Pennsylvania 16601 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (814) 943-0545 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.
USAID Director Rajiv Shah "says shelter and rubble removal are immediate priorities in the reconstruction efforts in earthquake-devastated Haiti," VOA News reports. Shah briefed the House Foreign Relations Subcommittee on the Western Hemisphere Thursday, and also "said between 300,000 and 400,000 units of shelter are needed. He said aid workers are trying to provide about 135,000 transitional structures right now."
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy.
Results from a survey carried out in Colorado, USA, show that a small but significant number of children in the region are killed or injured by firearms every year.
› Verified 2 days ago
NPI Number | 1821197187 |
Organization Name | THRIFT DRUG INC |
Doing Business As | RITE AID PHARMACY 11011 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 600 Chestnut Avenue, Altoona, PA 16601 |
Phone Number | 814-943-0545 |
News Archive
The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.
USAID Director Rajiv Shah "says shelter and rubble removal are immediate priorities in the reconstruction efforts in earthquake-devastated Haiti," VOA News reports. Shah briefed the House Foreign Relations Subcommittee on the Western Hemisphere Thursday, and also "said between 300,000 and 400,000 units of shelter are needed. He said aid workers are trying to provide about 135,000 transitional structures right now."
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy.
Results from a survey carried out in Colorado, USA, show that a small but significant number of children in the region are killed or injured by firearms every year.
› Verified 2 days ago
News Archive
The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.
USAID Director Rajiv Shah "says shelter and rubble removal are immediate priorities in the reconstruction efforts in earthquake-devastated Haiti," VOA News reports. Shah briefed the House Foreign Relations Subcommittee on the Western Hemisphere Thursday, and also "said between 300,000 and 400,000 units of shelter are needed. He said aid workers are trying to provide about 135,000 transitional structures right now."
GTx, Inc. (Nasdaq: GTXI), today announced that following a planned safety review, an independent Data Safety Monitoring Board (DSMB) has recommended that the company continue as planned the pivotal Phase III clinical trial evaluating toremifene 20 mg for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia (PIN), a precancerous lesion of the prostate.
On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy.
Results from a survey carried out in Colorado, USA, show that a small but significant number of children in the region are killed or injured by firearms every year.
› Verified 2 days ago
Barrett Vision Center Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 515 26th St, Altoona, Pennsylvania 16602 Phone: (814) 942-3200 | |
Broad Avenue Pharmacy Llc Type: Pharmacy Location: 2329 Broad Ave, Altoona, Pennsylvania 16601 Phone: (814) 943-1310 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 801 Logan Blvd, Altoona, Pennsylvania 16602 Phone: (814) 942-0545 | |
Central Orthotic & Prosthetic Co In Type: Prosthetic/Orthotic Supplier Location: 1019 Logan Blvd, Altoona, Pennsylvania 16602 Phone: (814) 943-5041 | |
Chartwell Pennsylvania Lp Type: DME Supplier - Parenteral & Enteral Nutrition Location: 1216 Pleasant Valley Blvd, Altoona, Pennsylvania 16602 Phone: (814) 941-0106 |